Source: PR Newswire

Press Release: Altavant Sciences : Altavant Sciences to Provide Corporate and Clinical Update at 2019 Respiratory Innovation Summit

CARY, N.C. and BASEL, Switzerland, May 9, 2019 /PRNewswire/ -- Altavant Sciences, a company in the Roivant family focused on clinical development of novel therapies for pulmonary arterial hypertension (PAH) and other indications, today announced that it has been invited to present at the...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Bill Symonds's photo - CEO of Altavant Sciences

CEO

Bill Symonds

CEO Approval Rating

90/100

Altavant Sciences is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases. Read more